Chronic alcohol consumption results in bone loss through increased bone resorption and decreased bone formation. These effects can be reversed by estradiol (E2) supplementation. Soy diets are suggested to have protective effects on bone loss in men and women, as a result of the presence of soy protein-associated phytoestrogens such as genistein (GEN). In this study, male mice were pair-fed (PF), a control diet, an ethanol (EtOH) diet, or EtOH diet supplemented with 250 mg/kg of GEN for 8 weeks to test if GEN protects against bone loss associated with chronic drinking. Interestingly, alcohol consumption reduced cortical area and thickness and trabecular bone volume in both EtOH and EtOH/GEN groups when compared to the corresponding PF and PF/GEN controls, P < 0.05. However, in the trabecular bone compartment, we observed a significant increase in overall trabecular bone density in the PF/GEN group compared to the PF controls. Bone loss in the EtOH-treated mice was associated with the inhibition of osteoblastogenesis as indicated by decreased alkaline phosphatase staining in ex vivo bone marrow cultures, P < 0.05. GEN supplementation improved osteoblastogenesis in the EtOH/GEN cultures compared to the EtOH group, P < 0.05. Vertebral expression of bone-formation markers, osteocalcin, and runt-related transcription factor 2 (Runx2) was also significantly up-regulated in the PF/GEN and EtOH/GEN groups compared to the PF and EtOH-treated groups. GEN supplementation also increased the expression of receptor activator of nuclear factor κ-B ligand (RANKL) in the PF/GEN, an increase that persisted in the EtOH/GEN-treated animals (P < 0.05), and increased basal hydrogen peroxide production and RANKL mRNA expression in primary bone marrow cultures in vitro, P < 0.05. These findings suggest that GEN supplementation increases the overall bone remodeling and, in the context of chronic alcohol consumption, does not protect against the oxidative stress-associated EtOH-mediated bone resorption.
SetchellKDLydeking-OlsenE. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr2003; 78: 593S–609.
2.
KhoslaSMeltonLJ IIIAtkinsonEJO’FallonWMKleeGGRiggsBL. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab1998; 83: 2266–74.
3.
RiggsBLKhoslaSMeltonLJ III. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res1998; 13: 763–73.
4.
SmithEPBoydJFrankGRTakahashiHCohenRMSpeckerBWilliamsTCLubahnDBKorachKS. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med1994; 331: 1056–61.
5.
WuJWangXXChibaHHiguchiMTakasakiMOhtaAIshimiY. Combined intervention of exercise and genistein prevented androgen deficiency-induced bone loss in mice. J Appl Physiol (1985)2003; 94: 335–42.
6.
MaDFQinLQWangPYKatohR. Soy isoflavone intake inhibits bone resorption and stimulates bone formation in menopausal women: meta-analysis of randomized controlled trials. Eur J Clin Nutr2008; 62: 155–61.
7.
KuiperGGLemmenJGCarlssonBCortonJCSafeSHvan der SaagPTvan derBBGustafssonJA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology1998; 139: 4252–63.
8.
MariniHMinutoliLPolitoFBittoAAltavillaDAtteritanoMGaudioAMazzaferroSFrisinaAFrisinaNLubranoCBonaiutoMD'AnnaRCannataMLCorradoFAdamoEBWilsonSSquadritoF. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann Intern Med2007; 146: 839–47.
9.
NewtonKMLaCroixAZLevyLLiSSQuPPotterJDLampeJW. Soy protein and bone mineral density in older men and women: a randomized trial. Maturitas2006; 55: 270–7.
10.
MonroeDGGetzBJJohnsenSARiggsBLKhoslaSSpelsbergTC. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERα or ERβ. J Cell Biochem2003; 90: 315–26.
11.
SliwinskiLFolwarcznaJNowinskaBCegielaUPytlikMKaczmarczyk-SedlakITrzeciakHTrzeciakHI. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system. Acta Biochim Polym2009; 56: 261–70.
12.
YoonH-KChenKBaylinkDJLauK-HW. Differential effects of two protein tyrosine kinase inhibitors, tyrphostin and genistein, on human bone cell proliferation as compared with differentiation. Calcif Tissue Int1998; 63: 243–9.
13.
SpinozziFPagliacciMCMiglioratiGMoracaRGrignamiFRiccardiCNicolettiI. The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkatt T-leukemia cells. Leuk Res1994; 18: 431–9.
14.
CallaciJJJuknelisDPatwardhanASartoriMFrostNWezemanFH. The effects of binge alcohol exposure on bone resorption and biomechanical and structural properties are offset by concurrent bisphosphonate treatment. Alcohol Clin Exp Res2004; 28: 182–91.
15.
ChakkalakalDA. Alcohol-induced bone loss and deficient bone repair. Alcohol Clin Exp Res2005; 29: 2077–90.
16.
MercerKEWynneRALazarenkoOPLumpkinCKHogueWRSuvaLJChenJRMasonAZBadgerTMRonisMJ. Vitamin D supplementation protects against bone loss associated with chronic alcohol administration in female mice. J Pharmacol Exp Ther2012; 343: 401–12.
17.
WezemanFHJuknelisDHimesRCallaciJJ. Vitamin D and ibandronate prevent cancellous bone loss associated with binge alcohol treatment in male rats. Bone2007; 41: 639–45.
18.
ClarkMKSowersMFDekordiFNicholsS. Bone mineral density and fractures among alcohol-dependent women in treatment and in recovery. Osteoporos Int2003; 14: 396–403.
19.
Wuermser LA, Achenbach SJ, Amin S, Khosla S, Melton LJ III. What accounts for rib fractures in older adults? J Osteoporos 2011;457–591.
20.
ChenJRHaleyRLHidestrandMShankarKLiuXLumpkinCKSimpsonPMBadgerTMRonisMJ. Estradiol protects against ethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-kappaB ligand in osteoblasts. J Pharmacol Exp Ther2006; 319: 1182–90.
21.
ShankarKHidestrandMHaleyRSkinnerRAHogueWJoCHSimpsonPLumpkinCKJrAronsonJBadgerTMRonisMJ. Different molecular mechanisms underlie ethanol-induced bone loss in cycling and pregnant rats. Endocrinology2006; 147: 166–78.
22.
RonisMJChenYBadeauxJBadgerTM. Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAr, LXR, and SREBP signaling. J Nutr2009; 139: 1431–8.
23.
ChenJRSinghalRLazarenkoOPLiuXHogueWRBadgerTMRonisMJ. Short term effects on bone quality associated with consumption of soy protein isolate and other dietary protein sources in rapidly growing female rats. Exp Biol Med2008; 233: 1348–58.
24.
ZhangJLazarenkoOWuXTongYBlackburnMGomez-AcevedoHShankarKBadgerTMRonisMJChenJR. Differential effects of short term feeding of a soy protein isolate diet and estrogen treatment on bone in the pre-pubertal rat. PLoS One2012; 7: e35736–e35736.
25.
YuanJPWangJHLiuX. Metabolism of dietary soy isoflavones to equol by human intestinal microflora—implications for health. Mol Nutr Food Res2007; 51: 765–81.
26.
BouxseinMLBoydSKChristiansenBAGuldbergREJepsenKJMullerR. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res2010; 25: 1468–86.
27.
ChenJRLazarenkoOPHaleyRLBlackburnMLBadgerTMRonisMJ. Ethanol impairs estrogen receptor signaling resulting in accelerated activation of senescence pathways, whereas estradiol attenuates the effects of ethanol in osteoblasts. J Bone Miner Res2009; 24: 221–30.
28.
ChenJRShankarKNagarajanSBadgerTMRonisMJ. Protective effects of estradiol on ethanol-induced bone loss involve inhibition of reactive oxygen species generation in osteoblasts and downstream activation of the extracellular signal-regulated kinase/signal transducer and activator of transcription 3/receptor activator of nuclear factor-kappaB ligand signaling cascade. J Pharmacol Exp Ther2008; 324: 50–9.
29.
KomoriTYagiHNomuraSYamaguchiASasakiKDeguchiKShimizuYBronsonRTGaoYHInadaMSatoMOkamotoRKitamuraYYoshikiSKishimotoT. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell1997; 30: 755–64.
KimHKNelson-DooleyCDella-FeraMAYangJYZhangWDuanJHartzellDLHamrickMWBaileCA. Genistein decreases food intake, body weight and fat pad weight and causes adipose tissue apoptosis in ovariectomized female mice. J Nutr2006; 136: 409–11.
32.
ChenJRZhangJLazarenkoOPCaoJJBlackburnMLBadgerTMRonisMJJ. Soy protein isolates prevent loss of bone quantity associated with obesity in rats through regulation of insulin signaling in osteoblats. FASEB J2013; 27: 3514–23.
33.
ShankarKHidestrandMLiuXChenJRHaleyRPerrienDSSkinnerRALumpkinCKJrBadgerTMRonisMJ. Chronic ethanol consumption inhibits postlactational anabolic bone rebuilding in female rats. J Bone Miner Res2008; 23: 338–49.
34.
Alvisa-NegrinJGonzalez-ReimersESantolaria-FernandezFGarcia-Valdecasas-CampeloEVallsMRPelazas-GonzalezRDuran-CastellonMCde Los AngelesG-R. Osteopenia in alcoholics: effect of alcohol abstinence. Alcohol Alcohol2009; 44: 468–75.
35.
ManolagasSC. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocrinol Rev2010; 31: 266–300.
36.
ChenJRLazarenkoOPShankarKBlackburnMLLumpkinCKBadgerTMRonisMJ. Inhibition of NADPH oxidases prevents chronic ethanol-induced bone loss in female rats. J Pharmacol Exp Ther2011; 336: 734–42.
37.
Zhang J, Lazarenko O, Badger T, Ronis M, Chen J-R. Persistent effects of a soy diet in early dvelopment on bone in female rats. Exp Biol 2013;A233.7.
38.
PasotoSGYoshiharaLAMaedaLCBernikMMLotufoPABonfaEPereiraRM. Osteoporotic hip fractures in non-elderly patients: relevance of associated co-morbidities. Rheumatol Int2011; 32: 3149–53.
39.
Benetou V, Orfanos P, Pettersson-Kymmeer U, Bergstrom U, Svensson O, Johansson I, Berrino F, Tumino R, Borsch KB, Lund E, Peeters PH, Grote V, Li K, Altzibar JM, Key T, Boeing H, von Ruesten A, Norat T, Wark PA, Riboli E, Trichopoulou A. Mediterranian diet and incidence of hip fractures in a European cohort. Osteoporosis Int 2013;24:1587–98.
40.
KaludjerovicJWardWE. Neonatal administration of isoflavones attenuates deterioration of bone tissue in female but not male mice. J Nutr2010; 140: 766–72.
41.
LiYQXingXHWangHWengXLYuSBDongGY. Dose-dependent effects of genistein on bone homeostasis in rats' mandibular subchondral bone. Acta Pharmacol Sin2012; 33: 66–74.
42.
TurnerRTIwaniecUTAndradeJEBranscumAJNeeseSLOlsonDAWagnerLWangVCSchantzSLHelferichWG. Genistein administered as a once-daily oral supplement had no beneficial effect on the tibia in rat models for postmenopausal bone loss. Menopause2013; 20: 677–86.
43.
WardWEPiekarzAV. Effect of prenatal exposure to isoflavones on bone metabolism in mice at adulthood. Pediatr Res2007; 61: 438–43.
44.
WeaverCMAlekelDLWardWERonisMJ. Flavonoid intake and bone health. J Nutr Gerontol Geriatr2012; 31: 239–53.
